Plain-English translation of NCT07351045 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called enicepatide, which is designed to help people lose weight by working on two different systems in the body that control hunger and blood sugar. The study will compare this medication at three different doses against a placebo (inactive injection) to see which works best and is safest for people who are overweight or have obesity but do not have type 2 diabetes.
Many people struggle to lose weight through diet and exercise alone, and there is a need for new treatment options. This medication represents a newer approach that may help more people manage their weight effectively.
You likely qualify if…
You likely don't qualify if…
If you qualify and are accepted into the study, you will be randomly assigned to receive either the placebo injection or one of three different doses of the medication. You will give yourself a weekly injection at home. Throughout the study, you will attend visits with the research team to have your weight measured, answer questions about your health, and have blood tests done to monitor your safety and how well the treatment is working.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States